Talks

This talk presents a label-free plasmonic nanosensor platform capable of detecting circulating tumor DNA at femtomolar concentrations directly from clinical samples, bypassing conventional amplification steps. The approach leverages localized surface plasmon resonance shifts induced by target hybridization on gold nanostructured substrates.

Presented an overview of the group's ongoing research into nanosensor-based liquid biopsy platforms to faculty and postgraduate students, covering electrochemical biosensing, SERS detection, and current progress toward clinical validation of miRNA and ctDNA biomarker panels.

Delivered a keynote address surveying the translational landscape of single-cell transcriptomics in clinical diagnostics, with emphasis on liquid biopsy, early cancer detection, and the role of nanosensor platforms in bridging bench-to-bedside gaps.

Served as session chair for the Nucleic Acid Diagnostics and Liquid Biopsy track, coordinating speaker introductions, moderating Q&A discussions, and ensuring session timing across six oral presentations from international research groups.